Charlotte's Web Holdings (TSE:CWEB)
TSX:CWEB
Want to see TSE:CWEB full AI Analyst Report?
CWEB Stock Chart & Stats
C$0.28
>-C$0.01(-2.86%)
At close: 4:00 PM EST
C$0.28
>-C$0.01(-2.86%)
Day’s Range― - ―
52-Week RangeC$0.11 - C$1.33
Previous CloseN/A
Volume4.38K
Average Volume (3M)140.12K
Market Cap
C$140.69M
Enterprise ValueC$140.07M
Total Cash (Recent Filing)C$5.20M
Total Debt (Recent Filing)C$64.96M
Price to Earnings (P/E)―
Beta0.85
Next Earnings
Aug 06, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding270,549,930
10 Day Avg. Volume81,567
30 Day Avg. Volume140,116
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-28.04
Price to Sales (P/S)1.15
P/FCF Ratio-3.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.12
Revenue Forecast (FY)C$54.70M
Bulls Say, Bears Say
Bulls Say
Balance-sheet Cleanup (BAT)The BAT conversion and $10M placement materially reduces interest burden (~$3M/yr avoided) and injects fresh liquidity, simplifying a stressed capital structure. That durable reduction in financing cost and added working capital improves runway and the company’s ability to execute pilots and clinical programs.
Federal Medicare Pilot AccessCMMI pilot eligibility establishes a persistent federal pathway into accountable care channels and legitimizes hemp-derived products for provider procurement. ACO-managed budgets (up to $500/beneficiary) create a durable B2B channel that can drive repeat institutional demand and higher-margin sales over multiple years.
Cost Cuts And Margin RecoverySustained SG&A reductions and in-house manufacturing demonstrate structural cost reshaping and improved unit economics. Persistent lower operating expense and rising gross margins increase the chance of sustainable profitability, lower breakeven volumes, and better cash conversion as revenue recovers.
Bears Say
Negative Shareholders' Equity & LeverageNegative equity and substantial debt constrain financing options and heighten dilution or restructuring risk. Over time this erodes strategic flexibility, raises cost of capital, and can force dilutive equity raises or creditor concessions that limit the company’s ability to invest in growth or clinical programs.
Persistent Cash BurnConsistent negative operating and free cash flow require repeat external funding or severe cost cuts to sustain operations. Long-term cash burn undermines reinvestment capacity, increases dilution risk, and makes execution on Medicare rollout and DeFloria development contingent on successful financing or continued drastic cost control.
Regulatory Uncertainty (potential Hemp Ban)A possible federal restriction on hemp/THC content poses an industry-level existential risk that could materially shrink the addressable market, force product reformulation, or block institutional channels. This policy risk can negate operational gains and make long-term revenue visibility highly uncertain.
Charlotte's Web Holdings News
CWEB FAQ
What was Charlotte's Web Holdings’s price range in the past 12 months?
Charlotte's Web Holdings lowest stock price was C$0.10 and its highest was C$1.33 in the past 12 months.
What is Charlotte's Web Holdings’s market cap?
Charlotte's Web Holdings’s market cap is C$140.69M.
When is Charlotte's Web Holdings’s upcoming earnings report date?
Charlotte's Web Holdings’s upcoming earnings report date is Aug 06, 2026 which is in 55 days.
How were Charlotte's Web Holdings’s earnings last quarter?
Currently, no data Available
Is Charlotte's Web Holdings overvalued?
According to Wall Street analysts Charlotte's Web Holdings’s price is currently Overvalued.
Does Charlotte's Web Holdings pay dividends?
Charlotte's Web Holdings does not currently pay dividends.
What is Charlotte's Web Holdings’s EPS estimate?
Charlotte's Web Holdings’s EPS estimate is -0.03.
How many shares outstanding does Charlotte's Web Holdings have?
Charlotte's Web Holdings has 270,549,930 shares outstanding.
What happened to Charlotte's Web Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Charlotte's Web Holdings?
Currently, no hedge funds are holding shares in TSE:CWEB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Charlotte's Web Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.45%
12-Months-Change
Fundamentals
Return on Equity
-2065.45%
Trailing 12-Months
Asset Growth
-34.56%
Trailing 12-Months
Company Description
Charlotte's Web Holdings
Charlotte's Web Holdings, Inc. operates comprehensively in the hemp-derived cannabidiol (CBD) wellness market, covering cultivation, manufacturing, marketing, and sales. The company's extensive product line features liquid hemp extract oil tinctures, a variety of gummies designed for benefits such as sleep, stress relief, immune support, and post-exercise recovery, as well as easy-to-use capsules, topical CBD creams, and lotions. They also offer specialized products for pets. These offerings are available under recognized brands including Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids, such as CBD, cannabichromene, cannabigerol, and cannabinol, alongside beneficial terpenes, flavonoids, and other hemp compounds. Distribution occurs through various channels, including brick-and-mortar retail locations, healthcare providers, and direct-to-consumer sales via their online platform. The company is committed to advancing cannabinoid research; its CW Labs science division collaborates with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 as Stanley Brothers Holdings Inc., the company rebranded to Charlotte's Web Holdings, Inc. in July 2018 and is headquartered in Denver, Colorado.
CWEB Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized several transformative, strategic positives — a balance-sheet‑clearing BAT transaction with fresh capital, federal Medicare pilot eligibility (Substance Access BEI) allowing full‑spectrum CBD access into accountable care channels, meaningful clinical progress via DeFloria's Phase II clearance, substantial cost reductions (SG&A down ~21% YoY and ~44.5% over two years), and improved operating loss and margin runways. These positives are tempered by ongoing regulatory uncertainty (including a potential November 2026 hemp provision that could severely constrain the market), persistent net losses (Q4 net loss $11.4M; full‑year net loss ~$29.7M), a nonrecurring $1.3M inventory charge that depressed reported margins, and liquidity dependence on shareholder approval of the BAT transaction. On balance, the call conveyed constructive momentum and multiple high‑impact catalysts that materially improve the company’s strategic position, while acknowledging meaningful near‑term risks and the gradual timing of revenue realization from Medicare pilots.View all TSE:CWEB earnings summariesTechnical Analysis
Options Prices
Currently, No data available
---